EcoDrugPlus

Thymidine Phosphorylase

Ensembl ID : ENSOMYG00000075201
Gene Symbol: TYMP
1 Cross references
170 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSOMYG00000022502
Gene Symbol: TYMP
1 Cross references
170 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSOMYG00000018372
Gene Symbol: TYMS
2 Cross references
219 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSOMYG00000004650
Gene Symbol: TRHR
1 Cross references
195 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSOMYG00000072548
Gene Symbol: TRHR
1 Cross references
194 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSOMYG00000028174
Gene Symbol: TLR7
1 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSOMYG00000028170
Gene Symbol: TLR8
1 Cross references
174 Possible Orthologues:

Toll-Like Receptor 2

Ensembl ID : ENSOMYG00000024133
Gene Symbol: TLR2
1 Cross references
213 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSOMYG00000055808
Gene Symbol: TAAR1
1 Cross references
145 Possible Orthologues:

Transforming Growth Factor, Beta Receptor 1 A

Ensembl ID : ENSOMYG00000020012
Gene Symbol: TGFBR1A
1 Cross references
150 Possible Orthologues:

Transforming Growth Factor, Beta Receptor 1 A

Ensembl ID : ENSOMYG00000042730
Gene Symbol: TGFBR1A
1 Cross references
150 Possible Orthologues:

Transforming Growth Factor, Beta Receptor 1 B

Ensembl ID : ENSOMYG00000021847
Gene Symbol: TGFBR1B
2 Cross references
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).